What is Chitin Synthesis Inhibitor made off?
Chitin Synthesis Inhibitor is a laboratory created inert compound that acts solely on chitin based organisms such as Candida fungus. It is not broken down by the human body into any other chemical form and it does not cause any reaction in human body systems. It is made with natural oils and basic chemical elements to create a completely non toxic fungicide that is pharmaceutical graded.
How do I know if I have Candida?
Everyone has Candida yeast in there gut, it is natural and should be there. The problem arises when the Candida yeast in the gut manages to invade the bloodstream and develop into another form which is Candida fungus. Due to Candida being ever present in our bodies in the yeast form it makes it more difficult to test for as the test must be able to differentiate between fungus and yeast. This results in only blood testing as a reasonably reliable testing method.
With our treatment you can effectively cleanse your body of Candida fungus. As the treatment is safe and no side effects we often say it is better to treat as if you have it, than to ignore because you cannot do a reliable test….
How does Chitin Synthesis Inhibitor kill Candida?
Chitin Synthesis Inhibitor does not kill the fungus, what it does is make the fungus vulnerable to attack by your immune system. It is after the treatment that your own white blood cells will finally be able to lay siege to the fungal colony. The treatment removes the fungus ability to generate the chitin layer which makes the fungus so difficult to attack.
When will it work and I start to feel the benefits?
Some people start the program and feel better almost immediately or within a few days, noticing positive effects such as increased energy, better mental focus, better elimination, etc. For these folks, the die-off experience is still likely to occur, but probably a few weeks down the road.
How often do I need to take a course of chitin synthesis inhibitor?
We recommend to our personal clients that if you follow an average western diet which does contain a lot of hidden sugars and antibiotics in diary and meat, then it can be a wise choice to take this course every year as a flush to your system and to catch any new fungal growth colonies in there early stages
Will this treatment affect any other medications I am taking?
As chitin synthesis inhibitor is an inert compound it will not react with other medications.
Do I need a doctor’s prescription?
Do I need antifungals also?
You do not have to take antifungals with the treatment. Many people however do suffer with a strong die off reaction which can involve yeast infections flaring up. If this happens then a standard ázole’ treatment will help relieve the situation.
Is it suitable for children?
As a child’s immune system is still developing we would not recommend this treatment for anyone under 18 years of age.
Is it suitable if I am pregnant?
We would not recommend this treatment for pregnant women or women who are breast feeding.
What are the side effects?
The treatment has no side effects – however, a die off reaction can occur which is often confused with being a side effect. The compound is inert and so to have a side effect it would have to be causing some kind of reaction in your body which it cannot.
What is a die off reaction?
Individuals with Candida Related Complex (CRC) have an overgrowth of yeast in their bodies. Once Candida yeast populations in the intestines and/or systemic yeast levels have grown to the point that they cause symptoms, it is crucial to a full recovery that the yeast population is reduced to normal or even, for susceptible individuals, to below normal levels through the use of an anti-Candida diet and supplementary anti-fungal agents. However, there is a challenging ‘catch” involved with this essential strategy. Living yeast cause symptoms by releasing toxic metabolic by-products into your body. Unfortunately, as you kill them they will temporarily release even larger amounts of these toxins.Generally speaking, most folks experience die-off as an exaggeration of their existing Candida-related symptoms or as a worsening of chronic health conditions.
Feeling some of your symptoms worsen a bit might be alarming, but is encouraging in the sense that it confirms both the presence of Candida and its susceptibility to the anti-fungal you are using. Die-off is experienced differently by each person Most folks experience die-off at some point in their recovery. There really is, however, no sure way to predict what point or to what degree one is likely to feel it.
Others start treatment (in some cases even just diet change) and feel worse right off the bat in response to the temporary toxicity. They may experience flu-like symptoms (stuffiness, headache, general aches and pains), skin rashes, vaginal irritation/discharge, numbness, mental confusion, fatigue, brain fog, constipation, and/or diarrhoea.
The die-off reaction normally lasts from one day to one week and can come and go throughout the program (it is especially likely to occur during the first weeks of a new Phase of the program). However, as your body becomes stronger, your susceptibility to Candida toxins is reduced and thus so is your die-off symptoms.
The severity of an individual’s symptoms depends upon the weakness of the organs most affected by Candida, the strength of your immune system, the degree of Candida infestation, and the environmental and emotional stress you are experiencing. We all also have our own different approaches to self-treatment. Some of us are more self- aware and gentle with ourselves while others are still learning about what their bodies need and how to treat ourselves with patient, loving kindness. If we impatiently “push” our progress, we are likely to experience more severe die-off reactions.
What diet should I follow?
You should follow a healthy diet, one that does not restrict you. The goal is to have your immune system strong, and the best way to have a strong immune system is to fuel it well! If you want to cleanse also it is best to do the cleanse before the treatment.
Do I need to take it with fat rich content food?
By taking the treatment with fat rich food you ensure the uptake of the compound into the fat cells. This means that during the ten days rest from the course of tablets your fat cells will slowly release the treatment into your bloodstream. This means that there is a constant maintained level in your body.
Can my Candida be resistant to Chitin Synthesis Inhibitor?
Should resistance ever develop it would mean that the fungus is not using chitin anymore in its cell walls, and would therefore be more vulnerable to the immune system anyway. So far there is no record of a strain of Candida that does not use chitin based defences.
Will I need to take a second course?
Highly unlikely. As long as you have taken the course correctly you will be Candida free.
What is the History of the Treatment ?
FIELD OF THE INVENTION
The present invention relates to a new use of benzoylphenylureas derivatives. More particularly, the present invention relates to benzoylphenylureas derivatives for use in combating fungal infections.
BACKGROUND OF THE INVENTION
Fungi are causative agents of various superficial skin lesions. The fungi live on the surface of the skin and use keratin as major solutions of nutrients. Fungi are found on various skin regions including in the legs, in the genital area, below the nails, etc. In addition, occasionally, particularly in individuals with an immune deprivation, fungi can develop on various other tissues such as on the oral mucosa. Furthermore, there are occasional fungi infections which may be systemic.
The fungi cells are typically surrounded by cell walls that contain complex polysaccharides, primarily chitin, chitosan, glucans and mannans.
U.S. Pat. No. 4,798,837, discloses N-benzoyl-N’-2,5-dichloro-4-hexafluoropropyloxy-phenylureas which were found to be effective. One of these compounds, known by the generic name is Lufenuron.
GENERAL DESCRIPTION OF THE INVENTION
In accordance with the invention it was found that Lufenuron administration is effective in combating and controlling fungal infection, especially such caused by dermatophytes.
The term “effective amount” should be understood as meaning an amount effective in achieving a therapeutic effect which may be manifested either in a permanent or temporary improvement in the subject’s condition, or in reduction of a fungal infection load. The effective amount may depend, inter alia, on the therapeutic regiment, the type of infection being treated, namely whether it is systemic, topical, etc., on the type of subject treated, i.e. whether it is human or a non human animal, as well as the type of animal, on the age of the subject, etc.
The pharmaceutical composition of the invention may, for example be provided in the form of a powder, lyophilizate, etc., for mixing with a physiological solution, e.g. saline for the purpose of parenteral administration. By a further example, the pharmaceutical solution of the invention may be formulated as an oral dosage form, e.g. in the form of a pill or a capsule. In addition, for some applications, the pharmaceutical composition of the invention may also be formulated in the form of a liquid solution intended for oral administration. Furthermore, the composition of the invention may also be formulated for topical administration.
The invention allows a therapeutic treatment of a variety of fungal infections. These may include systemic infections as well as topical fungal infections. In particular, and by a preferred embodiment, the present invention allows treatment of skin fungal infections in both humans and animals, nail or genital fungal infections in humans, eye fungal infections or ear fungal infections in both humans and animals, and others. Particular examples of fungal infections which may be treated in accordance with the invention are caused by dermatophytes such as those of the genus Microsporum (e.g. Microsporum Canis) which cause various skin fungal infections of the skin, nails or hair; those of the genus Aspergillas, and yeasts, e.g. Malassezia or Candida.